What does APOTHEEK GLIBERT-LOX do?

APOTHEEK GLIBERT-LOX is a pharmacy in Ronse. Private Limited, started on 5 October 2010, 2 establishments.

What is the address of APOTHEEK GLIBERT-LOX?

The registered office of APOTHEEK GLIBERT-LOX is located at Jules Bordetlaan 32, 9600 Ronse.

Is APOTHEEK GLIBERT-LOX still active?

Yes. According to the CBE (30 October 2026) APOTHEEK GLIBERT-LOX is active, legal situation “Normale toestand”, started on 5 October 2010.

Is APOTHEEK GLIBERT-LOX registered on Peppol?

Yes, APOTHEEK GLIBERT-LOX is registered on the Peppol network with ID 0208:0829917251.

What is the enterprise number of APOTHEEK GLIBERT-LOX?

The enterprise number of APOTHEEK GLIBERT-LOX is BE0829917251.

When was APOTHEEK GLIBERT-LOX founded?

APOTHEEK GLIBERT-LOX was founded on 5 October 2010.

Who are the directors of APOTHEEK GLIBERT-LOX?

According to the 2025 annual accounts, the directors of APOTHEEK GLIBERT-LOX are: Rode Magnolia BV, Anne Lox, Bart Glibert.

Is APOTHEEK GLIBERT-LOX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 October 2010; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account; 2 establishments in the CBE.

How much profit did APOTHEEK GLIBERT-LOX make in 2025?

APOTHEEK GLIBERT-LOX posted a profit after taxes of € 212,434 in financial year 2025.

What is the revenue of APOTHEEK GLIBERT-LOX?

As a small company, APOTHEEK GLIBERT-LOX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 493,775.

How much does an employee at APOTHEEK GLIBERT-LOX earn?

The average wage cost per full-time employee at APOTHEEK GLIBERT-LOX was € 69,700 in 2025: staff costs of € 174,345 for 2.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK GLIBERT-LOX have?

According to the 2025 annual accounts, APOTHEEK GLIBERT-LOX has 2.5 full-time equivalents (FTE).

Does APOTHEEK GLIBERT-LOX have a website?

Yes, APOTHEEK GLIBERT-LOX has a website at apotheekglibert.be.

APOTHEEK GLIBERT-LOX (Private Limited) - Ronse

Dossier APOTHEEK GLIBERT-LOX, printed on 30 October 2026 from databakkes.be/en/0829917251/apotheek-glibert-lox. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK GLIBERT-LOX from Ronse, company number BE0829917251, closed financial year 2025 with a result of € 212,434 after tax. For that financial year APOTHEEK GLIBERT-LOX recorded a gross margin of € 493,775 and equity of € 504,639. Compared with financial year 2024, the result moved from € 209,229 to € 212,434. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.

What it is worth Growing

€ 504,639

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 212,434

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 209,553

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 161,000 paid out

76 % of the profit went to the shareholders, mostly to RODE MAGNOLIA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.5

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 174,345

▼ 4% vs 2024

€ 69,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 20,153

▲ 17% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 17,737

▼ 66% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 111,018

▲ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 44,502

▲ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 471,102 Gross margin 2022: € 471,102 First fiscal year in the series	€ 463,889 Gross margin 2023: € 463,889 ▼ 2% vs 2022 (€ 471,102) Unfavourable step	€ 500,202 Gross margin 2024: € 500,202 ▲ 8% vs 2023 (€ 463,889) Favourable step	€ 493,775 Gross margin 2025: € 493,775 ▼ 1% vs 2024 (€ 500,202) Unfavourable step	▼ 1%
Profit after taxes	€ 237,235 Profit after taxes 2022: € 237,235 First fiscal year in the series	€ 181,142 Profit after taxes 2023: € 181,142 ▼ 24% vs 2022 (€ 237,235) Unfavourable step	€ 209,229 Profit after taxes 2024: € 209,229 ▲ 16% vs 2023 (€ 181,142) Favourable step	€ 212,434 Profit after taxes 2025: € 212,434 ▲ 2% vs 2024 (€ 209,229) Favourable step	▲ 2%
Equity	€ 449,835 Equity 2022: € 449,835 First fiscal year in the series	€ 444,977 Equity 2023: € 444,977 ▼ 1% vs 2022 (€ 449,835) Unfavourable step	€ 453,206 Equity 2024: € 453,206 ▲ 2% vs 2023 (€ 444,977) Favourable step	€ 504,639 Equity 2025: € 504,639 ▲ 11% vs 2024 (€ 453,206) Favourable step	▲ 11%
Total debts	€ 503,783 Total debts 2022: € 503,783 First fiscal year in the series	€ 432,863 Total debts 2023: € 432,863 ▼ 14% vs 2022 (€ 503,783) Favourable step	€ 388,667 Total debts 2024: € 388,667 ▼ 10% vs 2023 (€ 432,863) Favourable step	€ 341,345 Total debts 2025: € 341,345 ▼ 12% vs 2024 (€ 388,667) Favourable step	▼ 12%
Cash	€ 451,934 Cash 2022: € 451,934 First fiscal year in the series	€ 380,265 Cash 2023: € 380,265 ▼ 16% vs 2022 (€ 451,934) Unfavourable step	€ 259,063 Cash 2024: € 259,063 ▼ 32% vs 2023 (€ 380,265) Unfavourable step	€ 209,553 Cash 2025: € 209,553 ▼ 19% vs 2024 (€ 259,063) Unfavourable step	▼ 19%
Retained profit	€ 326,835 Retained profit 2022: € 326,835 First fiscal year in the series	€ 321,977 Retained profit 2023: € 321,977 ▼ 1% vs 2022 (€ 326,835) Unfavourable step	€ 330,206 Retained profit 2024: € 330,206 ▲ 3% vs 2023 (€ 321,977) Favourable step	€ 381,639 Retained profit 2025: € 381,639 ▲ 16% vs 2024 (€ 330,206) Favourable step	▲ 16%
Dividend	€ 220,000 Dividend 2022: € 220,000 First fiscal year in the series	€ 186,000 Dividend 2023: € 186,000 ▼ 15% vs 2022 (€ 220,000) Unchanged	€ 201,000 Dividend 2024: € 201,000 ▲ 8% vs 2023 (€ 186,000) Unchanged	€ 161,000 Dividend 2025: € 161,000 ▼ 20% vs 2024 (€ 201,000) Unchanged	▼ 20%
Bank debt	€ 122,215 Bank debt 2022: € 122,215 First fiscal year in the series	€ 87,756 Bank debt 2023: € 87,756 ▼ 28% vs 2022 (€ 122,215) Favourable step	€ 52,931 Bank debt 2024: € 52,931 ▼ 40% vs 2023 (€ 87,756) Favourable step	€ 17,737 Bank debt 2025: € 17,737 ▼ 66% vs 2024 (€ 52,931) Favourable step	▼ 66%
Balance sheet total	€ 953,618 Balance sheet total 2022: € 953,618 First fiscal year in the series	€ 877,839 Balance sheet total 2023: € 877,839 ▼ 8% vs 2022 (€ 953,618) Unchanged	€ 841,873 Balance sheet total 2024: € 841,873 ▼ 4% vs 2023 (€ 877,839) Unchanged	€ 845,985 Balance sheet total 2025: € 845,985 Unchanged (€ 841,873) Unchanged
Employees (FTE)	1.8 Employees (FTE) 2022: 1.8 First fiscal year in the series	2.5 Employees (FTE) 2023: 2.5 ▲ 0.7 vs 2022 (1.8) Unchanged	2.5 Employees (FTE) 2024: 2.5 Unchanged (2.5) Unchanged	2.5 Employees (FTE) 2025: 2.5 Unchanged (2.5) Unchanged

Key figures of APOTHEEK GLIBERT-LOX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK GLIBERT-LOX?

What happened at APOTHEEK GLIBERT-LOX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 13, 2026 New annual accounts for financial year 2025: profit of € 212,434 (▲ 2% vs 2024). Source: NBB ↗
Jun 1, 2019 New establishment in Ronse. KBO
Oct 5, 2010 New establishment in Ronse. KBO
Oct 5, 2010 Start of the company according to the CBE. KBO

In short

From € 237,235 profit in 2022 to € 212,434 profit in 2025.

Paid € 221,829 in corporate taxes since 2022.

Best year ever: 2022, with € 237,235 profit.

On average € 197,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

RODE MAGNOLIA 100%

The stake of RODE MAGNOLIA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK GLIBERT-LOX

Behind APOTHEEK GLIBERT-LOX are Rode Magnolia BV, Anne Lox and Bart Glibert. The shares are held by RODE MAGNOLIA (100%).

Directors

According to the 2025 annual accounts

Rode Magnolia BV

Director · represented by Pieter Glibert

Anne Lox

Director

Bart Glibert

Director

Also active at: GLIBERT BART

Shareholders

RODE MAGNOLIA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Jules Bordetlaan 32

9600 Ronse

2.291.822.166

Stationsstraat 33

9600 Ronse

Active since 1 June 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekglibert.be

Canonical: https://www.apotheekglibert.be/

Technologies

BootstrapCloudflare CDNJSNginxjQuery

Hosting & Email

Email provider

Self-hosted

Hosting

COMBELL-AS, BE

Website info

HTTPS Ja

Languages NL

Features

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number: 0829.917.251
VAT number: BE 0829.917.251
Registered office: Jules Bordetlaan 32, 9600 Ronse
Names & denominations: APOTHEEK GLIBERT-LOX
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 October 2010
Peppol: Active · Active since 9 Dec 2025
Contact: apotheekglibert.be
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗